On the other hand, the observation that at least a percentage of NPM1-mutated AML may derive from CD34-negative hematopoietic stem cells, raises the question of a possible relationship between absent/low expression of CD34 and cytoplasmic dislocation of mutant NPM1 [12]. This evidence concerns the gene CD34 and acute myeloid leukemia.